HiLung will be presenting at the 26th LINK-J Member's Meetup: Drug Discovery & Regenerative Medicine, taking place on Friday, April 10, 2026, at Nihonbashi Life Science Hub and online.
This edition of the event will focus on drug discovery and regenerative medicine.
At HiLung, we are reshaping how drug discovery support, safety assessment, and disease research are conducted through our high-fidelity human respiratory platform powered by human iPSC-derived respiratory organoids.
During the event, Toshio Suzuki, Director / Head of Translational Science, will introduce HiLung’s proprietary R&D and globally expanding CRO solutions, built on alveolar organoids, airway and alveolar models, and alveolar macrophage co-culture systems.
HiLung’s strength lies in making human-specific disease biology, drug efficacy, and toxicity responses visible—insights that are often difficult to capture with conventional animal models or simplified 2D culture systems—and translating those insights into better, faster R&D decision-making.
A networking session will follow the presentations, and we look forward to meeting and speaking directly with those interested in novel modality development in respiratory disease, efficacy and toxicity assessment, regenerative medicine, and collaboration opportunities.

[How to Register]
For more details and registration, please visit the official LINK-J website below:
https://www.link-j.org/event/article-51278.html

We look forward to welcoming you.

*Excerpt from the LINK-J event website